F/m Emerald Life Sciences Innovation ETF closed at $44.55 on Sep 28, up 0.18%, 8.0% below its 52-week closing high. Volume of 759 shares was 0.26× its 20-day average (below normal).
Split-adjusted performance: -6.2% over one month, +34.6% over six months, +54.8% over one year.
Short interest was 24.7K shares at the Sep 15 settlement, up 24.0% from the prior report (11.2 days to cover).
No recent articles focused on F/m Emerald Life Sciences Innovation ETF.
Quick answers
What is LFSC's market cap?
$123.70M, based on the Sep 28 close of $44.55.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology